Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aveir DR Real-World Evidence Post-Approval Study

NCT: NCT05935007 · RECRUITING

NCT IDNCT05935007
StatusRECRUITING
Start Date2023-10-31
Completion2030-12-31
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑